Can printed ‘skin’ help to heal burns without scars? 23%

By Andrea Teagle0% Knowable Magazine0%

7/4/2026, 4:11:00 PM

BS Summary: This article contains 32 faulty reasoning types, including Appeal to Authority, Recency Bias, and Hasty Generalization, with Optimism Bias as the most egregious example at 26.8% saturation with 447 hits. Analysis detected 2,373 faulty-reasoning hits from 1,668 analyzed words, generating a BS Score of 36.3% and a BS Rank of 23% (16,885 of 21,887 articles). This article is better (less manipulative) than 77.10% of the article peer group.

A hand touches a scalding hot plate, sharp pain erupts and immediately, the body gets to work. 
Damaged cells send out distress signals; immune cells rush in. 
As inflammation subsides, a coordinated repair process begins. 
Eventually, collagen fibers aligned in tight parallel rows will replace much of the damaged tissue. 
The wound heals, but it does not resemble normal skin. 
For a small burn or cut, a scar is a small price to pay for rapid healing that mitigates the risk of infection. 
But in larger burn wounds, scarring can be devastating. 
Each year, 11 million people require hospital care for burns. 
Long after the wounds have healed, scarring can cause complications. 
Unlike the random, basket-weave pattern that makes normal skin flexible and resilient, scar tissue tightens as it heals and, once mature, grows more slowly than surrounding skin. 
This can hinder movement and, in children with extensive burns, interfere with normal growth and development. 
Severe scars often lack hair follicles, sweat glands and nerve endings, reducing the ability to experience touch and to regulate body temperature. 
Scientists have long tried to develop ways to nudge the body to build healthy tissue instead of defaulting to emergency repair. 
In recent years, 3D bioprinting technology has emerged as one of the most promising approaches. 
By depositing patients’ own, pre-cultured skin cells suspended in an ink-like gel, these printers can create personalized skin substitutes, kickstarting the regeneration process. 
While it is early days, the technology is coming closer to clinical reality. 
The key is accessing the body’s ability to rebuild, says wound healing researcher Johan Junker of Linköping University in Sweden. 
Our bodies, he says, “have been practicing this for millions of years, and we do it constantly, because our skin and every tissue in our body, more or less, always turns over. 
So why not just provide as good a set of building blocks as we can and then let nature do its thing?” 
Inks made of cells 
For nearly a century, the gold standard for closing severe burn wounds has been split-thickness skin grafts. 
Surgeons remove the outermost layer of skin, the epidermis, and a sliver of the underlayer, the dermis, from an unburned part of the patient’s body, and use it to cover the wound. 
But in cases of extensive burns, there may not always be enough healthy skin to graft. 
And while this approach improves healing and aesthetics, it doesn’t eliminate scarring, since much of the skin’s functionality resides in the dermis, which has been replaced only in part. 
(Harvesting skin from other parts of the body can introduce scarring there, too.) 
Personalized skin substitutes created using traditional culture methods  multiplying cells in a lab dish, then layering them into a premade gel scaffold  have recently shown that scarless healing is possible: A product called denovoSkin, which replaces the dermis as well as the epidermis, has been used to treat children with severe burns in compassionate use cases. 
However, this approach requires special laboratory facilities and takes several weeks, which matters since the longer a wound remains open, the worse the risk of scarring. 
And the more severe the wound, the harder it is to build a viable three-dimensional skin substitute. 
Bioprinting offers a way around some of these challenges, and a variety of research groups are working to find an optimal formula for the “ink” of such printable skin. 
The severe wounds such technologies could treat are an overlooked health burden, says Hafiza Parkar, a regenerative medicine researcher at the University of Pretoria in South Africa, who is developing a 3D bioprinted skin substitute. 
Wound healing affects every single part of medicine, Parkar says, and the burden falls hardest on low- and middle-income countries. 
In Sweden, Junker, with colleague materials scientist Daniel Aili and others, recently designed a bioink that could improve healing, which has been dubbed “skin in a syringe.” 
They began with fibroblasts  the main cells of skin’s middle layer, the dermis  collected from abdominal skin from tummy tuck procedures, and then grew the cells on porous gelatin beads in a bioreactor. 
Fibroblasts produce proteins that form the skin’s scaffolding, and release growth factors that dampen inflammation, helping to promote healing. 
In three days, the team found, the cells had formed dense microtissues. 
The scientists then added microbeads laden with these cells to hyaluronic acid, which will serve as the bioink hydrogel base that holds everything together. 
Naturally occurring in the body, this water-binding molecule comprises molecular chains that, with a bit of chemistry, will cross-link, forming a firm gel akin to skin’s natural scaffolding. 
Usefully, it liquefies under pressure, behaving like ink as it passes through a syringe or printing nozzle. 
Spheres of gelatin are seeded with skin cells and then mixed with a water-binding gel to yield “skin in a syringe,” shown here in a scanning electron microscope image. 
CREDIT: COURTESY OF LINKÖPING UNIVERSITY 
Tests in which the bioprinted skin construct was implanted beneath the skin of mice showed that the cells survived printing and began forming healthy dermal tissue, a promising, albeit early, sign for scarless healing. 
“We’re kind of tricking the cells in the wound,” Junker says. 
“Instead of ‘Oh no, I’m in a huge wound, this is horrible, I need to scar it up as fast as I can,’ tricking it into more of a ‘Oh OK, it’s time for me to do my regular thing and just turn over tissue and regenerate, as I always do.’ 
The team is now testing the bioink in pigs, whose skin and wound-healing processes closely resemble those of humans, before moving to clinical trials, which will reveal more about its ability to diminish scarring. 
Once it reaches the clinic, the bioink will likely be applied via syringe, says Junker. 
However, bedside robotic printing arms are on the horizon. 
Printing precisely 
In Sydney, Australia, one such robotic printer called LIGŌ has just undergone a clinical trial, making it the first to be tested in people. 
Developed by biotechnology company Inventia Life Science, LIGŌ is designed to map a patient’s wound and print a precisely matched construct directly into it, nanoliter by nanoliter. 
“All we’re doing is structurally placing cells in the correct position to help the body reach that healing capacity and reinstate the integrity of skin,” says burn surgeon scientist and study lead Joanneke Maitz. 
“Instead of using an incubator in a laboratory, the body itself almost functions as the incubator.” 
For simplicity, Maitz and her colleagues printed onto the donor sites  the wounds left behind where participants’ skin was removed for grafting  rather than the burns themselves. 
They used only epidermal cells, the skin’s top layer, harvested from a biopsy during the same operation. 
Participants reported less pain at the sites treated with LIGŌ than those treated with regular dressings, and the trial, reported in a meeting of the American Burn Association, confirmed that the treatment had no adverse effects. 
In the next phase, the team will compare scarring outcomes. 
Although printing directly into a wound has the advantage of faster deployment, building a three-layered construct directly at wound sites remains, for now, a challenge. 
Bench-top bioprinters get around this by working outside the body under controlled conditions. 
Regenerative medicine expert Anthony Atala and his team at the Wake Forest Institute for Regenerative Medicine in Winston-Salem, North Carolina, are using that approach. 
They are creating a full-thickness skin substitute that uses cells from all three of the skin’s layers. 
Their construct might help with the most severe wounds by replacing elements of even the deepest skin layer, the hypodermis, which normally supports the healing of shallower tissue. 
The trade-off is that cells must be cultured for three to four weeks before the substitute skin is printed and applied to the wound. 
The basics of printing skin substitutes include harvesting cells, culturing those cells, creating an ink and printing the “skin.” 
In this simplified graphic, cells from three different skin layers are used. 
Some approaches use cells from only one skin layer, while others add additional cell types, such as follicle cells for hair, melanocytes for pigment and endothelial cells for blood vessels. 
Atala says that automating the creation of skin substitutes through 3D bioprinting could help make them more cost-effective. 
“What the printer does, is it gives you scalability,” he says. 
“You can reproduce the technology  at the same time, over and over again." 
The team tested in mice a three-layer skin substitute that used all six of the main human cell types found in skin (cells from the three skin layers and for hair follicles, blood vessels and pigment). 
The substitute encouraged rapid healing, and normal-looking skin, the team reported in Science Translational Medicine. 
They also recorded blood-vessel regrowth, a major challenge in skin substitute research. 
In pigs, wounds treated with a similar skin substitute (using the four main pig skin cells) healed with a basket-weave structure, contrasting with the scarring and greater contraction of those treated with just hydrogel or a skin substitute made with non-personalized cells. 
The substitute-treated wounds also produced more healing-promoting molecules and fewer scar-driving ones. 
The team is now fine-tuning the manufacturing process before running clinical trials. 
For 3D bioprinted skin substitutes to work as hoped in severe wounds, the body will need to assemble the inks’ cellular building blocks into new blood vessels, nerves and hair follicles, something no construct has yet achieved. 
But Atala’s pig results, showing blood vessel regrowth and reduced scarring, suggest that the field is moving in the right direction. 
Upcoming trials and future studies using different bioinks will reveal whether researchers can harness the body’s own regenerative capacity to achieve scarless healing and perhaps change the gold standard of care for burn survivors. 
Editor’s note: This article was amended on June 16, 2026, to clarify that the LIGŌ study results were presented at a conference, not as a journal article; only the abstract appeared in the Journal of Burn Care & Research. 
Article reasoning-pattern comparisonThis article: 2.9%Andrea Teagle: 0.7%Popular Science: 2.2%Confirmation Bias2.9%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.8%Anchoring Bias0.0%This article: 2.2%Andrea Teagle: 0.5%Popular Science: 2.7%Availability Heuristic2.2%This article: 0.7%Andrea Teagle: 0.2%Popular Science: 1.2%Representativeness Heuristic0.7%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.5%Hindsight Bias0.0%This article: 1.6%Andrea Teagle: 1.3%Popular Science: 2.9%Overconfidence Bias1.6%This article: 6.6%Andrea Teagle: 1.9%Popular Science: 3.5%Framing Effect6.6%This article: 2.8%Andrea Teagle: 1.0%Popular Science: 0.4%Loss Aversion2.8%This article: 1.0%Andrea Teagle: 0.3%Popular Science: 0.7%Status Quo Bias1.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Sunk Cost Effect0.0%This article: 26.8%Andrea Teagle: 18.8%Popular Science: 4.6%Optimism Bias26.8%This article: 3.7%Andrea Teagle: 0.9%Popular Science: 0.7%Pessimism Bias3.7%This article: 6.5%Andrea Teagle: 2.1%Popular Science: 3.0%Negativity Bias6.5%This article: 6.4%Andrea Teagle: 1.6%Popular Science: 0.7%Self-Serving Bias6.4%This article: 1.7%Andrea Teagle: 0.4%Popular Science: 0.3%Fundamental Attribution Error1.7%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Actor-Observer Bias0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.4%In-Group Bias0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.2%Out-Group Homogeneity Bias0.0%This article: 7.8%Andrea Teagle: 1.9%Popular Science: 2.1%Halo Effect7.8%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Horn Effect0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Dunning-Kruger Effect0.0%This article: 9.5%Andrea Teagle: 2.4%Popular Science: 0.9%Recency Bias9.5%This article: 2.3%Andrea Teagle: 0.6%Popular Science: 0.3%Primacy Effect2.3%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Blind-Spot Bias0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Ad Hominem0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Straw Man0.0%This article: 10.8%Andrea Teagle: 3.4%Popular Science: 4.2%Appeal to Authority10.8%This article: 2.0%Andrea Teagle: 0.5%Popular Science: 0.8%False Dilemma2.0%This article: 0.5%Andrea Teagle: 0.1%Popular Science: 0.3%Slippery Slope0.5%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Circular Reasoning0.0%This article: 8.5%Andrea Teagle: 5.8%Popular Science: 4.1%Hasty Generalization8.5%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Red Herring0.0%This article: 3.5%Andrea Teagle: 0.9%Popular Science: 0.6%Bandwagon3.5%This article: 5.7%Andrea Teagle: 1.4%Popular Science: 2.9%Appeal to Emotion5.7%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.6%Begging the Question0.0%This article: 1.6%Andrea Teagle: 0.4%Popular Science: 2.2%Post Hoc (False Cause)1.6%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Tu Quoque0.0%This article: 2.0%Andrea Teagle: 0.5%Popular Science: 0.5%Burden of Proof2.0%This article: 7.1%Andrea Teagle: 3.0%Popular Science: 0.4%Appeal to Nature7.1%This article: 4.2%Andrea Teagle: 1.0%Popular Science: 0.4%Composition/Division4.2%This article: 3.5%Andrea Teagle: 0.9%Popular Science: 2.2%Anecdotal3.5%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%No True Scotsman0.0%This article: 1.7%Andrea Teagle: 0.4%Popular Science: 2.0%Ambiguity (Equivocation)1.7%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Gambler’s Fallacy0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.2%Middle Ground0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Personal Incredulity0.0%This article: 2.0%Andrea Teagle: 0.5%Popular Science: 0.2%Special Pleading2.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.1%Genetic Fallacy0.0%This article: 0.7%Andrea Teagle: 0.2%Popular Science: 1.5%Unattributed Quote0.7%This article: 0.7%Andrea Teagle: 0.2%Popular Science: 0.8%Quote-first Misdirection0.7%This article: 3.8%Andrea Teagle: 0.9%Popular Science: 3.8%Biased Writer Voice3.8%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 1.3%Indoctrination0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Politically Left Leaning Bias0.0%This article: 0.0%Andrea Teagle: 0.0%Popular Science: 0.0%Politically Right Leaning Bias0.0%This article: 1.4%Andrea Teagle: 1.1%Popular Science: 2.8%Attempt to Sell a Product or S…1.4%

1668 words analyzed.

Speakers

5speakers18%attributed speech1,364writer words
Voice mapSelect a segment to jump to its words
Writer's voice • 9 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 10 words • 0.0% coverageWriter's voice • 8 words • 0.0% coverageWriter's voice • 15 words • 0.0% coverageWriter's voice • 10 words • 0.0% coverageWriter's voice • 23 words • 100.0% coverageWriter's voice • 9 words • 0.0% coverageWriter's voice • 10 words • 0.0% coverageWriter's voice • 10 words • 0.0% coverageWriter's voice • 27 words • 100.0% coverageWriter's voice • 16 words • 0.0% coverageWriter's voice • 22 words • 0.0% coverageWriter's voice • 21 words • 0.0% coverageWriter's voice • 15 words • 0.0% coverageWriter's voice • 23 words • 0.0% coverageWriter's voice • 13 words • 0.0% coverageJohan Junker • 20 words • 0.0% coverageJohan Junker • 32 words • 0.0% coverageJohan Junker • 22 words • 0.0% coverageWriter's voice • 4 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 32 words • 0.0% coverageWriter's voice • 16 words • 0.0% coverageWriter's voice • 29 words • 0.0% coverageWriter's voice • 13 words • 0.0% coverageWriter's voice • 58 words • 0.0% coverageWriter's voice • 26 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 29 words • 0.0% coverageHafiza Parkar • 35 words • 0.0% coverageHafiza Parkar • 20 words • 0.0% coverageWriter's voice • 27 words • 0.0% coverageWriter's voice • 35 words • 0.0% coverageWriter's voice • 19 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 24 words • 0.0% coverageWriter's voice • 28 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 29 words • 0.0% coverageLinköping University • 5 words • 0.0% coverageWriter's voice • 34 words • 0.0% coverageJohan Junker • 11 words • 100.0% coverageJohan Junker • 51 words • 0.0% coverageWriter's voice • 34 words • 0.0% coverageJohan Junker • 15 words • 0.0% coverageWriter's voice • 9 words • 0.0% coverageWriter's voice • 2 words • 0.0% coverageWriter's voice • 24 words • 0.0% coverageWriter's voice • 27 words • 0.0% coverageJoanneke Maitz • 34 words • 0.0% coverageJoanneke Maitz • 16 words • 0.0% coverageWriter's voice • 29 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 36 words • 100.0% coverageWriter's voice • 10 words • 0.0% coverageWriter's voice • 25 words • 0.0% coverageWriter's voice • 13 words • 0.0% coverageWriter's voice • 24 words • 0.0% coverageWriter's voice • 17 words • 0.0% coverageWriter's voice • 28 words • 0.0% coverageWriter's voice • 24 words • 0.0% coverageWriter's voice • 19 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 30 words • 0.0% coverageAnthony Atala • 18 words • 0.0% coverageAnthony Atala • 11 words • 0.0% coverageAnthony Atala • 14 words • 0.0% coverageWriter's voice • 36 words • 0.0% coverageWriter's voice • 15 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 42 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 12 words • 0.0% coverageWriter's voice • 37 words • 0.0% coverageWriter's voice • 21 words • 0.0% coverageWriter's voice • 34 words • 0.0% coverageWriter's voice • 39 words • 0.0% coverage
Selected voice

Joanneke Maitz

100%flagged-word coverage
50 attributed words16% of attributed speech72% writer coverage
0%2.5%5.0%Biased Writer Voice-4.6 ptsWriter: 4.6%Joanneke Maitz: 0.0%0.0%Attempt to Sell a Product -1.7 ptsWriter: 1.7%Joanneke Maitz: 0.0%0.0%

Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.

Loading…
Loading…
Loading…
Loading…

Analysis

Hover over highlighted words in the article to view the associated bias or fallacy analysis.